House Would Slow US FDA Budget Authority Increases In FY 2021
After two years of significant growth in non-user fee funds, House appropriators offer FDA a more modest increase for FY 2021.
You may also be interested in...
FDA Commissioner Robert Califf says the medical product programs have received a lot of attention and now it’s the food program’s turn.
Multiple stakeholders call for CBER to receive more prescription drug user fee funds amid growing cell and gene therapy popularity.
The change would let FDA forcibly pull prescription and over-the-counter drugs off the market just like vaccines, medical devices and other products.